Exton, PA, United States of America

Pavel Nikitin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Immunome, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pavel Nikitin. Retrieved from https://idiyas.com/inventor/pavel-nikitin-ev6glgt6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pavel Nikitin: Innovator in Antibody Therapy

Introduction

Pavel Nikitin is a notable inventor based in Exton, PA, who has made significant contributions to the field of biotechnology. His work primarily focuses on developing innovative solutions for treating viral infections, particularly those caused by SARS-CoV-2.

Latest Patents

Nikitin holds a patent for an antibody cocktail against the SARS-CoV-2 spike protein. This patent includes antibodies that are useful for treating SARS-CoV-2 infections in a subject. The patent also encompasses compositions comprising one or more antibodies, methods of treatment involving the administration of these antibodies, and kits that include one or more antibodies.

Career Highlights

Pavel Nikitin is currently associated with Immunome, Inc., where he applies his expertise in antibody development. His innovative approach has positioned him as a key player in the fight against COVID-19.

Collaborations

Some of his notable coworkers include Matthew K. Robinson and Michael John Morin, who contribute to the collaborative efforts at Immunome, Inc. Their combined expertise enhances the research and development of effective therapeutic solutions.

Conclusion

Pavel Nikitin's work in developing antibody therapies represents a significant advancement in the treatment of viral infections. His contributions are vital in the ongoing battle against diseases like COVID-19.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…